Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $131.02 million. The enterprise value is $157.81 million.
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 170.74 million shares outstanding. The number of shares has increased by 14.47% in one year.
| Current Share Class | 170.74M |
| Shares Outstanding | 170.74M |
| Shares Change (YoY) | +14.47% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 23.58% |
| Float | 124.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| Forward PS | n/a |
| PB Ratio | 5.46 |
| P/TBV Ratio | 5.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.91.
| Current Ratio | 1.12 |
| Quick Ratio | 1.03 |
| Debt / Equity | 3.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.96 |
Financial Efficiency
Return on equity (ROE) is -1,556.28% and return on invested capital (ROIC) is -16.84%.
| Return on Equity (ROE) | -1,556.28% |
| Return on Assets (ROA) | -9.70% |
| Return on Capital (ROIC) | -16.84% |
| Revenue Per Employee | $542,167 |
| Profits Per Employee | -$109,335 |
| Employee Count | 233 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.61% in the last 52 weeks. The beta is 2.12, so MCRB's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -37.61% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.89 |
| Relative Strength Index (RSI) | 41.33 |
| Average Volume (20 Days) | 2,047,434 |
Short Selling Information
The latest short interest is 20.44 million, so 11.97% of the outstanding shares have been sold short.
| Short Interest | 20.44M |
| Short Previous Month | 19.61M |
| Short % of Shares Out | 11.97% |
| Short % of Float | 16.37% |
| Short Ratio (days to cover) | 8.34 |
Income Statement
In the last 12 months, MCRB had revenue of $126.33 million and -$25.48 million in losses. Loss per share was -$0.18.
| Revenue | 126.33M |
| Gross Profit | -12.61M |
| Operating Income | -42.39M |
| Pretax Income | -82.68M |
| Net Income | -25.48M |
| EBITDA | -36.38M |
| EBIT | -42.39M |
| Loss Per Share | -$0.18 |
Full Income StatementBalance Sheet
The company has $66.82 million in cash and $93.61 million in debt, giving a net cash position of -$26.79 million or -$0.16 per share.
| Cash & Cash Equivalents | 66.82M |
| Total Debt | 93.61M |
| Net Cash | -26.79M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 23.92M |
| Book Value Per Share | 0.14 |
| Working Capital | 8.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$157.23 million and capital expenditures -$1.17 million, giving a free cash flow of -$158.39 million.
| Operating Cash Flow | -157.23M |
| Capital Expenditures | -1.17M |
| Free Cash Flow | -158.39M |
| FCF Per Share | -$0.93 |
Full Cash Flow StatementMargins
Gross margin is -9.98%, with operating and profit margins of -33.56% and -20.17%.
| Gross Margin | -9.98% |
| Operating Margin | -33.56% |
| Pretax Margin | -54.18% |
| Profit Margin | -20.17% |
| EBITDA Margin | -28.79% |
| EBIT Margin | -33.56% |
| FCF Margin | n/a |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.47% |
| Shareholder Yield | -14.47% |
| Earnings Yield | -19.44% |
| FCF Yield | -120.89% |
Analyst Forecast
The average price target for MCRB is $5.63, which is 633.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.63 |
| Price Target Difference | 633.65% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MCRB has an Altman Z-Score of -6.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.98 |
| Piotroski F-Score | 2 |